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Palliative care is not well understood in CF. Unmet needs of patients with CF, their families and staff were explored.
Method: Focus groups and interviews with forty-two participants (12 patients, 10 family members and 20 staff) were conducted at a university
teaching hospital.
Results: Thematic analysis identified six themes. Knowledge: Patients and families felt their knowledge of palliative care was limited.
Psychological frame: Hope and a positive psychological frame was essential to coping, however, this was a hindrance to the acquisition of
information. Denial as a coping strategy resulted in a lack of preparation for declining health. Treating team: High expectations were placed on the
treating team. Psychosocial support was valued. Communication: Timing, honest and clear discussions were important. Engagement with
palliative care service: Increased palliative care. Unmet needs: The emotional burden of caring for dying patients/families and balancing hope
against death was a challenge.
Conclusions: Opportunities exist to improve care.
© 2011 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.Keywords: Non-malignant; Palliative care; Attitudes; Beliefs; Cystic fibrosis1. Introduction
Palliative care offers comprehensive, interdisciplinary care
of patients and families facing a terminal illness, focusing
primarily on comfort [1] and encompassing the medical, social,
psychological and spiritual issues of both the patient and family
[2]. Those with non-malignant disease have been described,
however, as the “disadvantaged dying” [3] as they frequently
are not referred to palliative care services [4,5] and may benefit
from better resourced palliative care. There has been limited
attention exploring the palliative care and psychosocial needs of
adults with non-malignant disease facing end of life.☆ All authors declare that the answer to the questions on your competing interest fo
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1569-1993/$ - see front matter © 2011 Published by Elsevier B.V. on behalf of Eu
doi:10.1016/j.jcf.2011.03.002CF is a recessive, genetic disorder that leads to respiratory
failure and premature death. In a large centre with multidisci-
plinary teams and evidence-based guideline management, most
patients can expect to live beyond 30 years of age [4].
Multiple issues complicate end of life care planning in CF and
indeed many other non-malignant diseases. These include a lack
of consistent clinical staging to predict morbidity and survival,
uncertainty of eventual lung transplantation, recovery from
repeated acute exacerbations and poor recognition of the terminal
phase of illness [4,6]. The unpredictability of future outcomes can
be associatedwith psychological distress, anxiety, and depression,
which in turn adds to the complexity of palliative care provisionrm are all No and therefore have nothing to declare. Ethics approval was granted
mmunology & Respiratory Medicine, The Alfred Hospital, Commercial Road,
ropean Cystic Fibrosis Society.
Table 1
Key trigger questions relating to end of life care for the 3 groups.
Trigger questions — patients, families and staff
•What are your thoughts on how people are prepared for end of life in this illness?
• Thinking of end of life carewhatwould be themost difficult aspect of this for you?
• When should end of life issues be raised?
• How should information be best provided about end of life care issues?
• Who should raise the issues relating to end of life care?
•What are your thoughts about themanagement of symptomsduring the end of life
phase in this illness?
• Can you recall the experience of any discussion(s) regarding end of life care?
Trigger question — families only
• In general thinking back to your loved one's last week what did you find most
helpful?
• Looking back at your loved one's end of life care what would you have
changed? Looking back at your loved one's end of life care what would you
have changed?
• What are your thoughts about the support systems in place for this difficult
period of time?
• What was your experience/thoughts relating to how staff manage patient's
terminal phase of care?
• What would improve end of life care for patients/families?
Trigger question — staff only
• What would help you in your role when caring for patients/family facing end
of life care?
• How do you think staff manage patient's terminal phase of care?
254 M. Braithwaite et al. / Journal of Cystic Fibrosis 10 (2011) 253–257[7]. Whilst relatively well-developed models of end of life care
exist for malignant disease, few formal support structures exist to
aid those in the management of non-malignant organ failure [1].
Whilst respiratory failure can be supported with conservative
measures, lung transplantation remains the only option for those
with end-stage lung disease to gain significant improvement in
quality of life and longevity. Management approaches are
frequently complicated by the conflicting needs of preparation
for possible transplantation and simultaneously optimizing
possible end of life care. Limitations imposed by availability of
donor organs, age restriction, and specific contraindications
mean that many will not achieve this goal [8,9]. The dual
objectives of maintaining hope for transplantation whilst
simultaneously preparing for the end of life is a great challenge
for patients, families and staff. A model of care which maintains
current physical condition for those waiting for donor organs,
whilst also offering maximal benefit from palliative care options
could improve end of life care for patients, families and the staff
who care for them. This study explores the unmet needs and key
issues for CF patients, their families and the staff providing their
care whilst awaiting organ transplantation.
2. Methods
2.1. Recruitment Process
The study was undertaken within the Alfred Hospital Cystic
Fibrosis Service which treats over 250 adults from within a
catchment of over 3 million. This service is sited in a university
teaching hospital which also offers lung transplantation and
palliative care services. Through a randomisation schedule patients
were selected for participation from theAlfredCF service database
(n=250) (and had attended the Alfred CF clinic within the past
12 months). All participants were over 18 years and were able to
speak and understand English, without obvious cognitive
impairment as judged by the CF co-ordinator. A randomised
block design was employed. Using a measure of lung function,
ForcedExpiratoryVolume in the first second (FEV1), as ameasure
of illness severity, patients were allocated to one of three groups
(FEV1 severe b40%, moderate 41–70% and mild N70%) until 4
participantswere recruited into each group.The best FEV1 result in
the previous 6 months was used to determine their disease severity
group. Lung functionwas recorded using standard criteria [10] and
conducted during regular outpatient appointments. Twelve
individual interviews with patients were conducted (lasting
between 50 and 60 min) rather than focus groups due to the
confidential and sensitive nature of the topic aswell as to avoid any
infection control issues.
The next of kin (determined from the medical record) of the
CF patients who had died in the past 4 years were initially
contacted via telephone and then those expressing interest were
sent the participant information sheet. Ten individual face to
face interviews were conducted with family members due to the
sensitive nature of the content.
Alfred Cystic Fibrosis staff, currently providing clinical care
to CF patients (excluding those involved in the projects research
group), were sent a letter of invitation via the department's emaildistribution list. Four focus groups were conducted with at least
one representative from medical, nursing and allied health
attending the 60–80 min session.
All interviews and focus groups were conducted at the Alfred
Hospital using a semi-structured interview format (see Table 1)
(developed by the research team consisting of medical con-
sultants, palliative care consultants, psychologist, nurse, and
medical social worker) conducted by the same investigator who
had both psychology and research experience (neither known to
the patients, families or staff). Interviews and focus groups were
audio-taped, transcribed and analysed using thematic analysis.
Thematic analysis is a form of pattern recognition within the data,
where emerging themes become the categories for analysis [11].
All investigators read and independently coded the transcripts.
The research team generated coding categories from the data until
no further new categories were forthcoming (saturation) and then
applied the entire set of coding categories to all transcripts to
identify emergent themes. Focus groups and interviews were
ceased at a point when it was clear that no new themes were
emerging. Socio-demographic data were collected via a brief
questionnaire at the start of the focus group/interview. The project
received approval from the Alfred Hospital Institutional Ethics
Committee.
3. Results
A total of 42 participants were recruited for this study. Of the 18
patients approached, 12 agreed to participate (mean=35 years,
range=26–53 years, male 58%, mean FEV1 predicted=52%,
rangeFEV1predicted=23–98%) (response rate 67%).Recruitment
for families continued until saturation of information was reached.
Table 2




Patient: Once they start talking about that [palliative care] I
would think, “Oh, there really is no hope for me”.
Patient: Palliative care only becomes relevant after a
transplant has failed and a second is unlikely.
Family: I had only seen my mother die and she had cancer
so I guessed it may be similar but it wasn't and it would have
been helpful to have known more.
Staff: Palliative care is an old fashioned word with lots of
negative connotations that most people link with “death”.
Psychological
frame
Patient: I guess by now I would want it [information about
palliative care]. Yeah…but, no…cause I don't even think of
myself at this stage….It's like I think, in 5 years time I might
not be here but I probably thought that 5 years ago… at the
same time I know I can get a serious infection anytime
(Participant 8 — predicted FEV¹ 25%).
Patient: I would need some psychological support … I worry
about my family and how they will cope… knowing there is
counselling is a comfort to me.
Family: we had spoken about death and his wishes ....I could
just focus on (patient), say the things I needed to say… have
no regrets… prepare myself for the worst…which I think
helped me to accept
Family: I think that because he'd been through things before
and pulled through we were all in denial.
Staff: Sometimes we collude with patients/families hope
because we don't want to upset them.
Treating team Patient: The team has rescued me a number of times now
and I hope they can just keep doing that until transplant
Family: Even though there is no new information we still
want to hear from the team …otherwise you know you're not
being abandoned but you feel abandoned”.
Staff: There is sort of a myth of the ultimate rescuer; that the
team, the doctors are the ultimate rescuer.
Staff: It's very mentally exhausting for the staff and I think
we do a great job. You can just see the effects of how
exhausting it is afterwards.
Communication Patient: Probably the CF team [should initiate end of life
discussions] because I'll be forever in hope that I won't need
it.
Patient: Sometimes you want to know; sometimes you don't.
When you're feeling good you want to know and when you're
not feeling good you don't want to know.
Family: You get a bit overwhelmed by the information …
when you think about it later you think, “Oh, what did they
say?” It's as if your brain just puts a break on, a curtain falls
and you just don't take it in.
Staff: I think this comes back to the fact that it is hard to have
these sorts of discussions when someone is very unwell. I
think sometimes we think it will be hurtful to the patient to
discuss it when actually it is not.
Engagement with
PC service
Patient: I would not want my care managed by another team
but happy for others input
Family: I would have accepted the advice of palliative care
expertise
Staff: It is difficult isn't it because in a lot of ways we don't
like to wear people down with multiple team members on top
of them all day everyday when they're very sick.
Unmet needs Patient: I need to ask more questions but sometimes I don't
even know what to ask
Family: I would have liked more information when
(patient)'s health was better so I wasn't in shock.
Staff: I have had mothers say to me that they feel guilty
because their child was born with CF and I just look at the
parent and think “well, what do I say to that
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(mean=45 years, range 27–58 years, 50%male) (response rate of
76%). Family members consisted of either a parent (60%), a
partner (30%) or a sibling (10%). Four focus groups (n=5 per
group) were conducted with 20 treating team staff members and 2
clinicians from the palliative care service involved in CF care
(mean age=38 years, range 25–50 years, years of experience
with CF patients mean=9 years (range 2–24 years) and were
from a range of disciplines (25% medical, 40% nursing, 35%
allied health, and 20%male). The analysis of transcripts identified
6 overarching domains common to each group and several group-
specific themes and Table 2 displays the theme related quotes.
3.1. Knowledge of palliative care
Both patients and families reported their knowledge of
palliative care and end of life care in CF was limited. Existing
schemas of palliative care were frequently drawn from experiences
in oncology and tended to be associated with the final days of life,
imminent death and ‘giving up’. Many patients and families did
not want to discuss palliative care because of the perception that
engagement with end of life issues would bring death closer.
A number of patients indicated a desire to improve their
understanding of the end of life care process in CF. Increased
availability of information (both written and verbal) was
supported by all groups. The staff believed they had a good
understanding of palliative care but felt patients/families poor
understanding resulted in a lack of preparedness for end of life.
Transplantation was seen by patients as the solution to
deteriorating health, thus making it unnecessary to consider
palliative care. A universally held belief by patients is that they
would have the option of transplantation. Underlying this idea
was the notion that palliative care and transplantation were
mutually exclusive.
3.2. Psychological frame
Patients and families held the belief that a positive attitude
would have a similarly positive impact on prognosis. For patients
and families, the experience of having outlived previous life
expectancies and survived “near misses” promoted a belief that
the patient could beat current and future difficulties.
Many families felt that their desire to be positive (sometimes at
the expense of being realistic) laid the foundation for later regrets.
Families who discussed end of life issues with their loved one
before the final days reported the experience to be difficult but
beneficial to their psychological frame and subsequent bereave-
ment process.
The staff reported remaining positivewas important, however, it
served as a barrier when trying to discuss prognosis and treatment
options. The staff also expressed discomfort with the prospect that
theymay be depriving patients' comfortmeasures in the interests of
maximising the prospect for transplantation. The staff reported a
tension between providing maximum comfort to patients and yet
still maintaining hope for transplantation.
Another strong theme for patients and families was the benefit
of receiving psychological support. In addition to patients being
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believing psychological support, in the way of counselling, would
be available for their families when their health declines and for
bereavement support. For patients, confronting the reality of death
was the most difficult aspect to confront.3.3. Treating team
All three groups believed that the CF clinical service provided
(or would provide) a high standard of care. Patients placed high
expectations on the team to improve their health, which was
keenly felt by the treating team. The staff reported that the care of
a dying CF patient and subsequent family had a greater emotional
toll on them compared to patients with other illnesses. The age of
the patients, close long-term relationship with patient/family as
well as the death process for these patients made the work
challenging. Formal and informal support (e.g. debriefing) for the
staff was seen to be valuable in order to cope.
Families reported that at times they felt excluded by the team's
policy of focusing on the patient and if they were not included in
management discussions they felt a sense of abandonment.
Families needed the medical staff's continued interaction and
presence even if there was no change or new information. Patients
also placed great importance on the treating team and feared that
once nomore active treatmentswere being administered theymay
be abandoned by the treating team.3.4. Communication
Whilst patients and families desired honesty and recognised
the benefits of early discussions, there was concern about
discussions commencing too early. Fears that discussions
would potentially undermine their positive health disposition or
cause health to decline were barriers to communication. Whilst
patients reported they were open to end of life care discussions,
few had approached the issue or suggested when it would bemost
appropriate to start discussions. However, patients did state that
when discussing end of life care they wanted to do so with the
team member with whom they had the closest relationship,
regardless of the person's discipline. Both patients and families
seemed to feel the time to commence such discussions should be
seen as a decision for the treating team. Amongst the staff there
was consensus that end of life discussions were occurring too late.
Families reported wanting honest communication and early
warnings, but they also acknowledged that they may have failed
to hear such warnings during the stressful end of life period. As
such, there was a belief that end of life discussions should be
conducted as an open and flexible discourse occurring over
multiple interactions, with important messages being repeated.
Patients stressed the importance of having their wishes
understood by their family and the CF team, no matter how
sick they may become. The staff noted that poor communication
between a patient and his or her family led to greater difficulties
both in the end of life phase and in managing grief. To ensure a
consistent, informed approach to care written or individual
electronic plans were suggested.3.5. Palliative care service
Patients and families had little knowledge of, or exposure to,
palliative care services yet they were open to “other” than the
treatment team expertise. Patients and families expected their
end of life care to be managed within the treating clinical team.
The staff were in favour of greater involvement and integration
of palliative care services into the clinical team and believed
such services were currently being under-utilized. However, the
staff felt there was an unspoken expectation that they should be
able to manage their patients' care and did not want the patient
or family to feel a sense of abandonment by the treating team.
3.6. Unmet needs
Patients reported wanting more knowledge about end of life
care in CF, assistance around engaging end of life care and the
option of dying at home. Families wanted effective communi-
cation to keep them informed of treatment plans or changes. In
addition, families wanted information that assisted them to
prepare, to the extent possible, for declining health and ultimate
death. Meeting families' practical needs, such as providing
space at the hospital and accommodation for rural families, was
also important. The staff stressed the importance of ongoing
education to assist them in communicating with patients and
families about end of life issues and to manage the emotional
burden associated with this period.
4. Discussion
The findings from this study identify that there are a range of
psychological mechanisms used byCF patients, their families and
the staff in coping with end of life issues. Both patients and
families felt a strong need to maintain a positive psychological
frame and felt that discussing end of life may result in it occurring
sooner. Consistent with previous findings hope and fear are
intertwined [13], and patients oscillated between the desire for
knowledge and the avoidance of new information. Hope is
therefore maintained through periods of silence, allowing patients
to circumvent information that may diminish hope. Whilst
patients want to know more about end of life, few had actually
initiated it [4,12]. The staff found themselves colluding with
patients' positivity which hindered communication. The staff
have an opportunity to be proactive in discussions as both patients
and families felt it the responsibility of the treating team to raise
difficult discussions. In contrast when Chapman et al. [12]
conducted interviews with CF patients and observed team
meetings, they found the staff and patients to be comfortable
with an approach to death and dying that emphasised early
introduction of discussions and an open and honest dialogue. The
dynamics of communications, during end of life care, are
complex. The psychological mechanisms operating may not
always be transparent but an appreciation of their presencemay be
useful to manage difficult discussions.
Families readily acknowledge and expanded on their use of
denial as a defence mechanism to cope with the situation.
Concepts of death and dying identify denial as an early response
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[16]. It may also be unhelpful for families when patients survive
previous crises or “near misses” as this can set up the expectation
they will always recover. Adjustment means that denial gradually
diminishes and is replaced with acceptance but this process,
should it occur, takes significant time [16].
Many patients viewed lung transplantation as a solution,
providing increased life expectancy and negating the need to
consider palliative care services. These findings highlight
patients' limited understanding of the transplant process; as not
all patients are given the opportunity of organ transplantation and
many of those eligible will die on the waiting list [8,9].
Interestingly, whilst many patients and families saw transplanta-
tion and palliative care as being mutually exclusive, the staff
believed a dual model, where these are negotiated concurrently,
should exist. The staff did however acknowledge the challenge of
integrating life prolonging interventions and palliative care. They
reported feeling the tension between providingmaximum comfort
to patients and maintaining hope of transplantation. The
distinction between palliative and therapeutic or preventative
therapiesmay become blurred [12] further complicating treatment
plans. Indeed, continuation of many long-term treatments
provides comfort through their constancy. Patients and families
may benefit from an explicit dual policy approach: active
management being continued, but the possibility of death being
acknowledged as in other non-malignant diseases such as cardiac
failure [14]. Greater educational support for patients and families
before health declines, regarding the roles of both, may enable
choices that are better informed [15].
Providing psychosocial care for patients and families during
fluctuating and declining health can place a heavy burden on
health professionals [17,18]. Whilst the concept of “abandon-
ment” related to all groups for different reasons, the staff did not
want patients/families to feel neglected by them. This sentiment
was very powerful and impacted upon referrals to palliative care
expertise. Structure to support the staff in life-limiting complex
illnesses appears to be essential for the staff [17,18] but may also
have benefits for patients and families.
Some limitations of this study must be acknowledged. Sample
size, particularly for the patient and family groups, was dependent
on participants being sourced from a single clinical service. This
study was conducted at one sample time (rather than a designated
number of months post death of family member) therefore recall
may be evident in the results. Interviewer bias may possibly skew
the findings, however all interviews were transcribed and
analysed by the study team through a process of cross-reference
and validation.
End of life care is a particularly important component of cystic
fibrosis care. Patients/families may benefit from the continuity,
multidisciplinary care and focus on symptom control and
emotional support that are the hallmarks of a good palliative care
approach [14]. Amodel that maximises patient-determined quality
of life [1], provides a communication strategy and addresses the
complex physical and psychological issues, but is still flexible toincorporate individual differences is required. A communication
strategy that recognises needs, unspoken expectations and edu-
cation is important. Coping mechanisms that may be maladaptive
and negate effective pro-active management should be identified
and managed. In particular, giving teams permission to appreciate
patient's/families ambivalence and yet still translate important end
of life care information early may help to promote discussions and
normalise the process for all groups.Acknowledgment
This project received funding from a research grant from the
Australian Cystic Fibrosis Research Trust.References
[1] Billings JA. Recent advances: palliative care. BMJ 2000;321(7260):555–8.
[2] World Health Organisation. National cancer control programmes: Policies
and management guidelines. Geneva: Switzerland; 2002.
[3] Stewart S,McMurray JJ. Palliative care for heart failure. BMJ2002;325(7370):
915–6.
[4] Philip JA, Gold M, Sutherland S, Finlayson F, Ware C, Braithwaite M, et al.
End-of-life care in adults with cystic fibrosis. J Palliat Med 2008;11(2):
198–203.
[5] Rosenwax LK, McNamara BA. Who receives specialist palliative care in
Western Australia— and who misses out. Palliat Med 2006;20(4):439–45.
[6] Seamark DA, Seamark CJ, Halpin DM. Palliative care in chronic obstructive
pulmonary disease: a review for clinicians. J R SocMed 2007;100(5):225–33.
[7] SpathisA, Booth S. End of life care in chronic obstructive pulmonary disease:
in search of a good death. Int J Chron Obstruct PulmonDis 2008;3(1):11–29.
[8] Dellon EP, Leigh MW, Yankaskas JR, Noah TL. Effects of lung
transplantation on inpatient end of life care in cystic fibrosis. J Cyst
Fibros 2007;6(6):396–402.
[9] Ford D, Flume PA. Impact of lung transplantation on site of death in cystic
fibrosis. J Cyst Fibros 2007;6(6):391–5.
[10] Miller M, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al.
Standardisation of spirometry. Eur Respir J 2005;26(2):319–38.
[11] Daly J, Kellehear A, Gliksman M. The public health researcher: a
methodological approach. Australia: Oxford University Press. Melbourne;
1997.
[12] Chapman E, Landy A, Lyon A, Haworth C, Bilton D. End of life care for
adult cystic fibrosis patients: facilitating a good enough death. J Cyst
Fibros 2005;4(4):249–57.
[13] Leydon GM, Boulton M, Moynihan C, Jones A, Mossman J, Boudioni M,
et al. Cancer patients' information needs and information seeking
behaviour: in depth interview study. BMJ 2000;320(7239):909–13.
[14] Murray SA, et al. Dying of lung cancer or cardiac failure: prospective
qualitative interview study of patients and their carers in the community.
BMJ 2002;325(7370):929.
[15] Abbott J, Hart A, Morton A, Gee L, Conway S. Health-related quality of
life in adults with cystic fibrosis: the role of coping. J Psychosom Res
2008;64(2):149–57.
[16] Kubler-Ross E. On death and dying. New York: Mac-millan; 1969.
[17] Odling G, Norberg A, Danielson E. Care of women with breast cancer on a
surgical ward: nurses' opinions of the need for support for women,
relatives and themselves. J Adv Nurs 2002;39(1):77–86.
[18] Catalan J, Burgess A, Pergami A, Hulme N, Gazzard B, Phillips R. The
psychological impact on staff of caring for people with serious diseases:
the case of HIV infection and oncology. J Psychosom Res 1996;40(4):
425–35.
